Prognostic significance of tissue polypeptide-specific antigen (TPS) in patients with advanced non-small cell lung cancer
- 1 January 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (12) , 1783-1786
- https://doi.org/10.1016/0959-8049(94)00214-p
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysisThe Lancet, 1993
- Prognostic Value of the Tissue Polypeptide Antigen in Lung CancerChest, 1992
- Prognostic value of serum thymidine kinase, tissue polypeptide antigen and neuron specific enolase in patients with small cell lung cancerBritish Journal of Cancer, 1991
- Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysisCancer, 1990
- Usefulness of Tissue Polypeptide Antigen in Staging, Monitoring, and Prognosis of Lung CancerChest, 1988
- Tumor markers in bronchogenic carcinoma. Superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9Cancer, 1987
- A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1986
- Distribution of tissue polypeptide antigen (TPA) in normal human tissues: Immunohistochemical study on unfixed, methanol-, ethanol-, and formalin-fixed tissues.Journal of Histochemistry & Cytochemistry, 1985
- Regression Models and Life-TablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958